| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Feb 5, 2025 | Allogene Therapeutics, Inc. | SVP, General Counsel | Sell | 46.3 | -6,404 | -1.08% | ✗ | $11K |
| Aug 21, 2024 | Aug 23, 2024 | Allogene Therapeutics, Inc. | SVP, General Counsel | Sell | 42.5 | -28,310 | -5.93% | ✗ | $78.8K |